Loading...

ChromaDex Corporation

CDXCNASDAQ
Healthcare
Biotechnology
$7.87
$-0.07(-0.88%)

ChromaDex Corporation (CDXC) Stock Overview

Explore ChromaDex Corporation’s financial performance, market position, analyst ratings, and future outlook.

Revenue Growth
19.18%
19.18%
Profit Growth
$0.18
273.15%
EPS Growth
$0.18
242.86%
Operating Margin
16.28%
237.99%
ROE
33.88%
273.15%
Dividend Yield
0.00%
Analyst Recommendations data is not available for CDXCAnalyst Recommendations details for CDXC are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers, as well as to distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and IMMULINA, a Braun-type lipoproteins, including spirulina extracts and active compounds, which are used to support human immune function. It also offers analytical reference standards and services comprising supply of products to conduct quality control of raw materials and consumer products in dietary supplements, cosmetics, food and beverages, life sciences, and pharmaceutical industries. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation is headquartered in Los Angeles, California.

CEO

Mr. Frank Louis Jaksch Jr.

Employees

104

Headquarters

10900 Wilshire Boulevard, Los Angeles, CA

Founded

2008

Frequently Asked Questions